The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-15 of 15 articles
Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial
Slagboom T,
Toelg R,
Witzenbichler B,
Haude M,
Masotti M,
Ruiz Salmeron R,
Witkowski A,
Uematus M,
Takahashi A,
Waksman R,
Saito S
February 20, 2023 | 10.4244/EIJ-D-22-00526
BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months
Saito S,
Toelg R,
Witzenbichler B,
Haude M,
Masotti M,
Ruiz Salmeron R,
Witkowski A,
Uematsu M,
Takahashi A,
Waksman R,
Slagboom T
December 6, 2019 | 10.4244/EIJ-D-18-01214
Optical coherence tomography substudy of a prospective multicentre randomised post-market trial to assess the safety and effectiveness of the Firehawk cobalt-chromium coronary stent (rapamycin target-eluting) system for the treatment of atherosclerotic lesions: TARGET All Comers
Baumbach A,
Lansky A,
Onuma Y,
Asano T,
Johnson TW,
Anderson R,
Kiemeneij F,
Zeng M,
van Royen N,
Slagboom T,
Vlachojannis G,
Serruys P,
Wijns W
November 20, 2018 | 10.4244/EIJ-D-18-00226
Long-term clinical outcomes of a crystalline sirolimus-eluting coronary stent with a fully bioabsorbable polymer coating: five-year outcomes from the DESSOLVE I and II trials
Wijns W,
Vrolix M,
Verheye S,
Schoors D,
Slagboom T,
Gosselink M,
Benit E,
Kandzar D,
Donohoe D,
Ormiston J
April 6, 2018 | 10.4244/EIJ-D-17-00230
Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial
Vlachojannis G,
Smits P,
Hofma S,
Togni M,
Vázquez N,
Valdes M,
Voudris V,
Puricel S,
Slagboom T,
Goy J-J,
den Heijer P,
van der Ent M
July 20, 2015 | 10.4244/EIJV11I3A53
Safety and feasibility of a PAclitaxel-eluting balloon angioplasty in Primary Percutaneous coronary intervention in Amsterdam (PAPPA): one-year clinical outcome of a pilot study
Vos N,
Dirksen M,
Vink M,
van Nooijen F,
Amoroso G,
Herrman JP,
Kiemeneij F,
Patterson M,
Slagboom T,
van der Schaaf RJ
September 28, 2014 | 10.4244/EIJV10I5A101
Coronary artery treatment with paclitaxel-coated balloon using a BTHC excipient: clinical results of the international real-world DELUX registry
Toelg R,
Merkely B,
Erglis A,
Hoffmann S,
Bruno H,
Kornowski R,
Slagboom T,
Naber C,
Witzenbichler B,
Graf K,
Richardt G,
Hehrlein C
September 28, 2014 | 10.4244/EIJV10I5A102
Late catch-up in lumen diameter at five-year angiography in MACE-free patients treated with sirolimus-eluting stents in the Primary Stenting of Totally Occluded Native Coronary Arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II)
Teeuwen K,
Van den Branden B,
Rahel B,
Laarman G,
Thijssen J,
Kelder J,
Slagboom T,
ten Berg J,
Suttorp MJ
June 28, 2013 | 10.4244/EIJV9I2A36
Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study)
February 21, 2012 | 10.4244/EIJV7I10A190
Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial
Silber S,
Gutiérrez-Chico J-L,
Behrens S,
Witzenbichler B,
Wiemer M,
Hoffmann S,
Slagboom T,
Harald D,
Suryapranata H,
Nienaber C,
Naber C,
Chevalier B,
Serruys P
May 17, 2011 | 10.4244/EIJV7I1A13
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023